Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (1)
  • 2024 (4)
  • 2023 (3)
  • 2022 (2)
  • 2021 (4)
  • 2020 (3)
  • 2019 (2)
  • 2018 (9)

Subject

  • Drug Trafficking (24)
  • Take Back Day (24)
  • Prescription Drugs (20)
  • Outreach/Drug Prevention (18)
  • Public and Media Affairs - also see Congressional Affairs (16)
  • Press Conferences (11)
  • Synthetic drugs (11)
  • Fake Pills (10)
  • Arrests/Convictions - Major (8)
  • Diversion Division (8)
  • Fentanyl Awareness (8)
  • Red Ribbon (8)
  • Major Law Enforcement Operation (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Money Laundering (6)
  • Guns/Weapons (5)
  • One Pill Can Kill (5)
  • Intergovernmental Affairs (4)
  • Overdose (4)
  • Critical Incident (3)
  • Extraditions (3)
  • International/Foreign Operations (3)
  • Seizures (Drugs/Property) (3)
  • Gangs (2)
  • Scam Calls (2)
  • Dark Web- Internet Trafficking (1)
  • HIDTA (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Task Forces/Task Force Officers (1)
  • Congressional Affairs (12)
  • Pharmaceuticals/Pharmacists/Physicians (9)
  • OCDETF/Task Force (5)
  • Narcoterrorism (3)

Drug Name

  • Cocaine (5)
  • Fentanyl (4)
  • Oxycodone (3)
  • Methamphetamine (2)
  • Synthetic Opioids (2)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Heroin (1)
  • Ketamine (1)
  • Psilocybin (1)

Field Division

  • New England (336)
  • Washington, DC (123)
  • St. Louis (67)
  • Seattle (64)
  • Atlanta (61)
  • Miami (46)
  • Houston (44)
  • New York (29)
  • Chicago (28)
  • New Jersey (28)
  • El Paso (21)
  • Dallas (19)
  • San Diego (12)
  • San Francisco (10)
  • Louisville (7)
  • Los Angeles (6)
  • New Orleans (4)
  • Phoenix (4)
  • Rocky Mountain (4)
  • Omaha (2)
  • Detroit (1)
  • Philadelphia (1)
  • Sede (28)
Clear All Results
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

Mayo 08, 2025
WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
Mayo 08, 2025
PRESS RELEASE

China-Based Chemical Manufacturing Companies and Employees Indicted for Alleged Fentanyl Manufacturing and Distribution

Octubre 24, 2024
WASHINGTON – Eight China-based chemical companies and eight employees have been charged in the Middle District of Florida with federal crimes including attempted distribution of synthetic opioids and precursor chemicals used in the production of fentanyl. Five of the indictments also charge defendants with money laundering. “Today, the Justice Department...
Octubre 24, 2024
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

Agosto 29, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
Agosto 29, 2024
PRESS RELEASE

Federal Indictment Alleges Alliance Between Sinaloa Cartel and Money Launderers Linked to Chinese Underground Banking

Junio 18, 2024
Washington - The Justice Department today announced a 10-count superseding indictment charging Los Angeles-based associates of Mexico’s Sinaloa drug cartel with conspiring with money-laundering groups linked to Chinese underground banking to launder drug trafficking proceeds. During the conspiracy, more than $50 million in drug proceeds flowed between the Sinaloa Cartel...
Junio 18, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

Febrero 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
Febrero 07, 2024
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

Octubre 31, 2023
WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
Octubre 31, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

Mayo 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
Mayo 09, 2023
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

Febrero 24, 2023
WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...
Febrero 24, 2023
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

Diciembre 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
Diciembre 15, 2022
PRESS RELEASE

DEA Dedicates September 11th Memorial

Septiembre 09, 2022
WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...
Septiembre 09, 2022
Showing 1 - 10 of 28 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Siguiente página ›
  • Última página »

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster